1. Home
  2. SOPA vs CDIO Comparison

SOPA vs CDIO Comparison

Compare SOPA & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Society Pass Incorporated

SOPA

Society Pass Incorporated

HOLD

Current Price

$0.08

Market Cap

5.2M

Sector

Technology

ML Signal

HOLD

Logo Cardio Diagnostics Holdings Inc.

CDIO

Cardio Diagnostics Holdings Inc.

HOLD

Current Price

$1.96

Market Cap

4.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOPA
CDIO
Founded
2018
2017
Country
Singapore
United States
Employees
N/A
17
Industry
EDP Services
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
4.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SOPA
CDIO
Price
$0.08
$1.96
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$22.50
N/A
AVG Volume (30 Days)
2.3M
67.6K
Earning Date
05-19-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,171,635.00
N/A
Revenue This Year
$2.43
$171,906.75
Revenue Next Year
$71.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
45.00
N/A
52 Week Low
$0.07
$0.97
52 Week High
$6.28
$7.91

Technical Indicators

Market Signals
Indicator
SOPA
CDIO
Relative Strength Index (RSI) 19.75 52.58
Support Level N/A $1.68
Resistance Level $0.66 $2.18
Average True Range (ATR) 0.04 0.22
MACD -0.02 0.07
Stochastic Oscillator 2.06 53.78

Price Performance

Historical Comparison
SOPA
CDIO

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.

About CDIO Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

Share on Social Networks: